Probi Logo

Probi

ISIN

SE0001280355

Ticker

PROB

Sector

Health Care

Sub-Industry

Pharmaceuticals

Country

Sweden

Year Founded

1991

About Probi

Company Description

Probi is an international company focused exclusively on developing, producing, and delivering clinically proven probiotics. We’ve spent three decades exploring and refining solutions that make the health-enhancing benefits of probiotics available to people everywhere.

We are experts at managing stable, live bacteria from R&D through every stage of the manufacturing process, and into finished products, including bulk formats, supplements, and functional foods. Health concepts, formulations, and formats are supported by documentation.

Since our founding at Sweden’s Lund University, in 1991, Probi has expanded its presence to more than 40 markets. We hold more than 400 patents globally.

Served Area

Worldwide

Headquarters

Ideongatan 1A
22370, Lund
Sweden

Financial statements

Download as Excel
Line item in (sek) 01.01.2020 01.01.2021 01.01.2022 01.01.2023
Assets N/A 1,239,893,000.00 1,432,169,000.00 1,569,888,000.00
Noncurrent Assets N/A 830,081,000.00 958,586,000.00 1,029,591,000.00
Property Plant And Equipment N/A 103,076,000.00 166,678,000.00 212,352,000.00
Buildings N/A 939,000.00 7,002,000.00 19,934,000.00
Machinery N/A 17,986,000.00 38,899,000.00 64,606,000.00
Construction In Progress N/A 38,853,000.00 38,732,000.00 53,267,000.00
Other Property Plant And Equipment N/A 2,280,000.00 7,306,000.00 8,999,000.00
Goodwill N/A 278,238,000.00 307,011,000.00 353,887,000.00
Intangible Assets Under Development N/A 39,620,000.00 32,096,000.00 24,782,000.00
Deferred Tax Assets N/A 28,000.00 301,000.00 357,000.00
Current Assets N/A 409,812,000.00 473,583,000.00 540,297,000.00
Trade And Other Current Receivables N/A 95,864,000.00 128,744,000.00 100,346,000.00
Other Current Receivables N/A 2,785,000.00 3,705,000.00 3,941,000.00
Current Tax Assets Current N/A N/A 0.00 781,000.00
Cash and cash equivalents 206,960,000.00 215,552,000.00 251,017,000.00 323,706,000.00
Other Cash And Cash Equivalents N/A 215,552,000.00 251,017,000.00 323,706,000.00
Current Prepayments And Other Current Assets N/A 3,740,000.00 5,979,000.00 6,329,000.00
Equity And Liabilities N/A 1,239,893,000.00 1,432,169,000.00 1,569,888,000.00
Equity 1,152,126,000.00 1,115,203,000.00 1,265,541,000.00 1,410,567,000.00
Issued Capital N/A 58,221,000.00 58,221,000.00 58,221,000.00
Retained Earnings N/A 514,811,000.00 585,422,000.00 611,232,000.00
Additional Paidin Capital N/A 600,205,000.00 600,205,000.00 600,205,000.00
Equity Attributable To Owners Of Parent N/A 1,115,203,000.00 1,265,541,000.00 1,410,567,000.00
Noncurrent Liabilities N/A 34,874,000.00 67,481,000.00 59,081,000.00
Deferred Tax Liabilities N/A 3,906,000.00 13,359,000.00 13,833,000.00
Other Noncurrent Liabilities N/A 4,299,000.00 4,748,000.00 5,480,000.00
Current Liabilities N/A 85,910,000.00 85,788,000.00 86,407,000.00
Accruals Classified As Current N/A N/A 18,580,000.00 30,150,000.00
Other Current Liabilities N/A 4,204,000.00 4,496,000.00 5,052,000.00
Line item in (sek) 01.01.2020/
01.01.2021
01.01.2021/
01.01.2022
01.01.2022/
01.01.2023
Revenue From Interest 241,000.00 154,000.00 1,705,000.00
Revenue From Contracts With Customers 717,165,000.00 658,180,000.00 618,285,000.00
Profit Loss From Operating Activities 123,681,000.00 109,243,000.00 50,574,000.00
Profit Loss Before Tax 120,087,000.00 107,439,000.00 51,974,000.00
Income Tax Expense Continuing Operations 27,394,000.00 24,294,000.00 11,352,000.00
Profit (loss) 92,693,000.00 83,145,000.00 40,622,000.00
Profit Loss Attributable To Owners Of Parent 92,693,000.00 83,145,000.00 40,622,000.00
Line item in (sek) 01.01.2020 01.01.2021 01.01.2022 01.01.2023
Profit (loss) N/A 92,693,000.00 83,145,000.00 40,622,000.00
Adjustments For Income Tax Expense N/A 27,394,000.00 24,294,000.00 11,352,000.00
Adjustments For Decrease Increase In Inventories N/A -30,973,000.00 13,300,000.00 -8,936,000.00
Adjustments For Depreciation And Amortisation Expense N/A 72,780,000.00 73,285,000.00 85,682,000.00
Other Adjustments For Noncash Items N/A 3,419,000.00 2,274,000.00 4,036,000.00
Cash Flows From Used In Operating Activities N/A 143,364,000.00 154,195,000.00 156,094,000.00
Other Cash Payments To Acquire Equity Or Debt Instruments Of Other Entities Classified As Investing Activities N/A 53,032,000.00 55,891,000.00 0.00
Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities N/A 0.00 973,000.00 20,000.00
Purchase Of Property Plant And Equipment Classified As Investing Activities N/A 30,036,000.00 35,147,000.00 52,429,000.00
Purchase Of Intangible Assets Classified As Investing Activities N/A 13,334,000.00 7,416,000.00 12,180,000.00
Cash Flows From Used In Investing Activities N/A -96,402,000.00 -97,481,000.00 -64,589,000.00
Proceeds From Borrowings Classified As Financing Activities N/A 241,000.00 154,000.00 1,705,000.00
Payments Of Lease Liabilities Classified As Financing Activities N/A 13,146,000.00 12,418,000.00 13,743,000.00
Dividends Paid Classified As Financing Activities N/A 11,394,000.00 12,534,000.00 14,812,000.00
Interest Paid Classified As Financing Activities N/A 3,388,000.00 3,190,000.00 2,458,000.00
Cash Flows From Used In Financing Activities N/A -27,687,000.00 -27,988,000.00 -29,308,000.00
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes N/A 19,275,000.00 28,726,000.00 62,197,000.00
Effect Of Exchange Rate Changes On Cash And Cash Equivalents N/A -10,683,000.00 6,739,000.00 10,492,000.00
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes N/A 8,592,000.00 35,465,000.00 72,689,000.00
Cash and cash equivalents 206,960,000.00 215,552,000.00 251,017,000.00 323,706,000.00

Please note that some sums might not add up.

Filings & Publications

  • Consolidated Report 2022 - Q4 Swedish 🇸🇪 Published: 09.05.2023
  • Consolidated Report 2021 - Q4 Swedish 🇸🇪

Insider Trades

Date Trading entity / Person Association Trade type Volume
06.05.2022 Henrik Lundkvist Other Buy SEK 27,981.00
29.04.2022 Tom Rönnlund Other Buy SEK 122,296.00
28.04.2022 Tom Rönnlund Other Buy SEK 287,015.70
06.05.2020 Tom Rönnlund Other Buy SEK 100,000.00

Capital Markets Information

ISIN

SE0001280355

LEI

5493004CJOCT273MU397

Sub-Industry

Pharmaceuticals

Listed Stock Exchange

Nasdaq Stockholm

Contact Investor Relations Department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.